Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults-Reference-Cited by-同舟云学术

Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults

Published:2022-09 Issue:9 Volume:24 Page:954-961
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Harada Kaito^ORCID,Morita-Fujita Mari,Fukuda Takahiro,Ozawa Yukiyasu,Doki Noriko^ORCID,Toyosaki Masako,Maruyama Yumiko^ORCID,Kanda Yoshinobu,Ashida Takashi,Eto Tetsuya,Takada Satoru,Uchida Naoyuki,Ichinohe Tatsuo,Kanda Junya^ORCID,Onizuka Makoto,Atsuta Yoshiko,Kako Shinichi^ORCID,Arai Yasuyuki^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference39 articles.

1. How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia;Ravandi;Blood,2019

2. Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia;Abou Dalle;Curr Treat Options Oncol,2019

3. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia;Chalandon;Blood,2015

4. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia;Fielding;Blood,2014

5. US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL;Ravandi;Blood Adv,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensified conditioning regimens with total marrow irradiation/etoposide/cyclophosphamide and busulfan/etoposide/cyclophosphamide overcome the impact of pre‐transplant minimal residual disease on outcomes in high‐risk acute lymphoblastic leukemia patients in complete remission;Cancer Medicine;2024-01

2. Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease;Cytotherapy;2023-12

3. Allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: current status and future directions mainly focusing on a Chinese perspective;Expert Review of Hematology;2022-09-02